Nystatin and Enterobacter infection - a phase IV clinical study of FDA data

Summary:

Enterobacter infection is reported as a side effect among people who take Nystatin (nystatin), especially for people who are male, 60+ old, also take Insulin, and have Hyperglycemia.

The phase IV clinical study analyzes which people have Enterobacter infection when taking Nystatin. It is created by eHealthMe based on reports of 33,189 people who have side effects when taking Nystatin from the FDA, and is updated regularly.

What is Nystatin?

Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 33,567 Nystatin users. Check the latest studies of Nystatin.

What is Enterobacter infection?

Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae) is found to be associated with 267 drugs and 554 conditions by eHealthMe. Check the latest studies of Enterobacter infection.

On Jul, 15, 2026

33,189 people reported to have side effects when taking Nystatin.
Among them, 25 people (0.08%) have Enterobacter infection.

Could Nystatin cause Enterobacter infection?

Among these 25 people:

What is the gender of people who have Enterobacter infection when taking Nystatin? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Enterobacter infection when taking Nystatin? *

What are other drugs people take besides Nystatin? *

What are other side effects people have besides Enterobacter infection? *

Klebsiella Infection: 22 people, 88.00%
Enterococcal Infection: 13 people, 52.00%
Morganella Infection (infection by morganella morganii bacteria): 12 people, 48.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 12 people, 48.00%
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 11 people, 44.00%
Encephalopathy (functioning of the brain is affected by some agent or condition): 11 people, 44.00%
Septic Shock (shock due to blood infection): 11 people, 44.00%
Staphylococcal Infection (an infection with staphylococcus bacteria): 9 people, 36.00%
Chest Wall Abscess: 8 people, 32.00%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 8 people, 32.00%

What are the existing conditions these people have? *

Hyperglycemia (high blood sugar): 10 people, 40.00%
Gout (uric acid crystals building up in the body): 8 people, 32.00%
Sleep Disorder: 7 people, 28.00%
Oral Infection: 7 people, 28.00%
Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 28.00%
Immunodeficiency Disorders: 2 people, 8.00%
Wound Infection: 1 person, 4.00%
Stenotrophomonas Infection: 1 person, 4.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 4.00%
Postoperative Wound Infection: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nystatin and have Enterobacter infection?

- Check whether Enterobacter infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nystatin:

Nystatin (33,567 reports)

Browse all side effects of Nystatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enterobacter infection:

Enterobacter infection (267 drugs)

Browse all the conditions that are associated with Enterobacter infection:

Enterobacter infection (554 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nystatin (the active ingredients of Nystatin) and Nystatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.